ReviewNPJ breast cancer2026

Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology.

Giuseppe Di Grazia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.